Menu Search
Equities

Ingevity Corp

NGVT:NYQ

Ingevity Corp

Actions
Basic MaterialsChemicals
  • Price (USD)49.22
  • Today's Change0.81 / 1.67%
  • Shares traded131.88k
  • 1 Year change+25.08%
  • Beta1.6225
Data delayed at least 15 minutes, as of Nov 22 2024 19:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
  • 21-Nov-24
Select bar for recommendation details.
Recommendations21-Nov-24
Buy1
Outperform1
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The 4 analysts offering 12 month price targets for Ingevity Corp have a median target of 50.00, with a high estimate of 58.00 and a low estimate of 40.00. The median estimate represents a 3.28% increase from the last price of 48.41.
High19.8%58.00
Med3.3%50.00
Low-17.4%40.00

Earnings history & estimates in USD

On Oct 29, 2024, Ingevity Corp reported 3rd quarter 2024 earnings of 1.10 per share. This result exceeded the 0.90 consensus of the 4 analysts covering the company and under-performed last year's 3rd quarter results by 9.09%.
The next earnings announcement is expected on Feb 19, 2025.
Average growth rate+42.03%
Ingevity Corp reported annual 2023 earnings of 3.94 per share on Feb 21, 2024.
Average growth rate-3.34%
More ▼

Revenue history & estimates in USD

Ingevity Corporation had 3rd quarter 2024 revenues of 376.90m. This missed the 384.28m consensus estimate of the 4 analysts following the company. This was 4.00% below the prior year's 3rd quarter results.
Average growth rate-3.45%
Ingevity Corporation had revenues for the full year 2023 of 1.69bn. This was 1.43% above the prior year's results.
Average growth rate+7.45%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.